![Paul Clark](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Clark
Amministratore Delegato presso
Lilly ICOS LLC
Profilo
Paul N. Clark è un direttore indipendente di Agenus, Inc., un direttore non esecutivo indipendente principale di Keysight Technologies, Inc., un direttore indipendente di Agilent Technologies, Inc. e un presidente e amministratore delegato di Lilly ICOS LLC. Fa parte del Consiglio di amministrazione di Agenus, Inc., Keysight Technologies, Inc., Agilent Technologies, Inc. e Grifols Therapeutics, Inc. Clark è stato precedentemente impiegato come direttore indipendente di Amylin Pharmaceuticals, Inc., partner operativo di Genstar Capital LLC, presidente di ICOS Corp., direttore e vicepresidente esecutivo di Abbott Laboratories, vicepresidente delle vendite e del marketing di Marion Laboratories e partner operativo e consulente di Genstar Capital Management LLC. Ha anche fatto parte del consiglio di BIOLASE, Inc., Talecris Biotherapeutics Holdings Corp., Catalent Pharma Solutions, Inc., Catalent, Inc., Cerevast Neurorehab, Inc. e Harlan Laboratories, Inc. Si è laureato presso l'Università dell'Alabama e ha conseguito un MBA presso la Tuck School of Business di Dartmouth.
Posizioni attive di Paul Clark
| Società | Posizione | Inizio |
|---|---|---|
Lilly ICOS LLC
 Lilly ICOS LLC Pharmaceuticals: MajorHealth Technology Develops and markets medical drugs | Amministratore Delegato | - |
Grifols Therapeutics, Inc.
 Grifols Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops therapeutic products | Direttore/Membro del Consiglio | 27/10/2011 |
Precedenti posizioni note di Paul Clark
| Società | Posizione | Fine |
|---|---|---|
| AGILENT TECHNOLOGIES, INC. | Direttore/Membro del Consiglio | 21/12/2021 |
| KEYSIGHT TECHNOLOGIES, INC. | Presidente | 01/10/2019 |
| AGENUS INC. | Direttore/Membro del Consiglio | 15/06/2021 |
| BIOLASE, INC. | Presidente | 01/09/2017 |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Direttore/Membro del Consiglio | 01/09/2014 |
Formazione di Paul Clark
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
84
Relazioni di 1° grado
19
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 19 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Health Technology |
BIOLASE, Inc.
 BIOLASE, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, markets and sells laser systems for dental practitioners & their patients | Health Technology |
Agilent Technologies, Inc.
 Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
Agenus, Inc.
 Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Genstar Capital Management LLC
 Genstar Capital Management LLC Investment ManagersFinance Genstar Capital invests in private and public middle market companies located across the globe. The firm targets companies operating in the fields of financial services, healthcare, software and industrial sectors. It provides financing for corporate carve-outs and buyouts capital transactions. The firm takes a seat on the board of directors and also makes control investments. | Finance |
Lilly ICOS LLC
Lilly ICOS LLC Pharmaceuticals: MajorHealth Technology Develops and markets medical drugs | Health Technology |
Cerevast Medical, Inc.
 Cerevast Medical, Inc. Medical SpecialtiesHealth Technology Develops medical devices for the treatment of neurologic disorders | Health Technology |
Keysight Technologies, Inc.
 Keysight Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Provides electronic measurement instruments and systems | Electronic Technology |
The University of Alabama
 The University of Alabama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops therapeutic products | Health Technology |
Talecris Biotherapeutics Holdings Corp.
 Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Develops and markets plasma-derived protein therapy products | Health Technology |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Health Technology |
Marion Laboratories
 Marion Laboratories Medical DistributorsDistribution Services Wholesales drugs | Distribution Services |
Harlan Laboratories, Inc.
 Harlan Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides preclinical research tools and services | Commercial Services |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Catalent, Inc.
 Catalent, Inc. Pharmaceuticals: MajorHealth Technology Provides delivery technologies and development solutions | Health Technology |
Genstar Capital LLC
 Genstar Capital LLC Investment ManagersFinance Operates as a private equity firm | Finance |
